Digital Agenda Revealed: Innate Immune Stimulating Therapies
We are excited to release the digital event agenda for the Innate Immune Stimulating Therapies Summit, taking place on Wednesday, July 22. Download your copy here.
Join the discussion online with leaders in the field, from large pharma, key biotech, and academia, to discuss how to achieve safe and effective clinical and commercial translation of STING and TLR therapies. Check out the official event guide for more details. Hear from the likes of:
- Marc Damelin, Executive Director and Head of Biology, Mersana Therapeutics Inc
- Arthur Krieg, Chief Scientific Officer, Checkmate Pharmaceuticals
- Kimberly Schluns, Associate Professor, University of Texas MD Anderson Cancer Center
- Valerie Odegard, Chief Scientific Officer, Silverback Therapeutics
- Xingfeng Bao, Senior Director, Immuno-Oncology, H3biomedicine
- Glen Barber, Professor of the Department of Cell Biology, University of Miami Miller School of Medicine
- Michael Adams, Investigator, GlaxoSmithKline
And many more! See the full speaker list and what will be discussed here.
Be part of our online community as the industry comes together to share best practice, clinical progress and lessons learned on the journey so far to translate safe and effective innate immune stimulating therapies for patients in need.
Register this week to secure the best possible rate on your ticket.
Group discounts are automatically applied at checkout.
We hope to see you there!